References
- Griffith T S, Lynch D H. TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin Immunol 1998; 10: 559–563
- Walczak H, Miller R E, Ariail K, Gliniak B, Griffith T S, Kubin M, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157–163
- Ashkenazi A, Pai R C, Fong S, Leung S, Lawrence D A, Marsters S A, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999; 104: 155–162
- Lahm A, Paradisi A, Green D R, Melino G. Death fold domain interaction in apoptosis. Cell Death Differ 2003; 10: 10–12
- Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000; 191: 1095–1104
- Lunemann J D, Waiczies S, Ehrlich S, Wendling U, Seeger B, Kamradt T, et al. Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto) antigen-specific T cells. J Immunol 2002; 168: 4881–4888
- Deeg H J, Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med 1984; 35: 11–24
- Welniak L A, Blazar B R, Murphy W J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007; 25: 139–170
- Schmaltz C, Alpdogan O, Kappel B J, Muriglan S J, Rotolo J A, Ongchin J, et al. T cells require TRAIL for optimal graft-versus-tumor activity. Nat Med 2002; 8: 1433–1437
- Sato K, Nakaoka T, Yamashita N, Yagita H, Kawasaki H, Morimoto C, et al. TRAIL-transduced dendritic cells protect mice from acute graft-versus-host disease and leukemia relapse. J Immunol 2005; 174: 4025–4033
- Tateishi K, Ohta M, Guleng B, Kanai F, Tanaka Y, Asaoka Y, et al. TRAIL-induced cell death co-operates with IFN-γ activation in the graft-versus-tumor effect against colon tumors. Int J Cancer 2006; 118: 2237–2246
- Matsumura R, Umemiya K, Kagami M, Tomioka H, Tanabe E, Sugiyama T, et al. Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjogren's syndrome. Clin Exp Rheumatol 2002; 20: 791–798
- Matsuyama W, Yamamoto M, Higashino I, Oonakahara K I, Watanabe M, Machida K, et al. TNF related apoptosis inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood 2004; 104: 184–191
- Lub-de Hooge M N, de Vries E GE, de Jong S, Biji M. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 854–858
- Nomura S, Ishii K, Inami N, Uoshima N, Ishida H, Yoshihara T, et al. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentration after stem cell transplantation. Transpl Immunol 2007; 18: 115–121